# Amphastar Pharmaceuticals, Inc.: Form 8-K, filed Jan 12, 2021

- Company: [Amphastar Pharmaceuticals, Inc.](/companies/amph.md) (CIK 1297184)
- Form: 8-K
- Filed: 2021-01-12
- Accepted by EDGAR: Jan 12, 2021, 16:05 ET
- Period: 2021-01-12
- Accession: 0001558370-21-000171
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1297184/000155837021000171/amph-20210112x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1297184/000155837021000171/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1297184/000155837021000171/amph-20210112x8k.htm

Filed Jan 12, 2021.
Source: SEC EDGAR, the filing index for accession 0001558370-21-000171. Last ingested by Listed: Nov 6, 2026, 17:01 ET. No prices; not investment advice.